- Home
- ACIU vs PANL Comparison
ACIU vs PANL Comparison
Compare ACIU & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- PANL
- Stock Information
- Founded
- ACIU 2003
- PANL 1996
- Country
- ACIU Switzerland
- PANL United States
- Employees
- ACIU N/A
- PANL N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- PANL Marine Transportation
- Sector
- ACIU Health Care
- PANL Consumer Discretionary
- Exchange
- ACIU Nasdaq
- PANL Nasdaq
- Market Cap
- ACIU 332.4M
- PANL 289.9M
- IPO Year
- ACIU 2016
- PANL N/A
- Fundamental
- Price
- ACIU $3.15
- PANL $5.48
- Analyst Decision
- ACIU Strong Buy
- PANL Strong Buy
- Analyst Count
- ACIU 2
- PANL 1
- Target Price
- ACIU $12.00
- PANL N/A
- AVG Volume (30 Days)
- ACIU 151.5K
- PANL 214.5K
- Earning Date
- ACIU 11-05-2024
- PANL 11-12-2024
- Dividend Yield
- ACIU N/A
- PANL 7.32%
- EPS Growth
- ACIU N/A
- PANL N/A
- EPS
- ACIU N/A
- PANL 0.47
- Revenue
- ACIU $48,505,404.00
- PANL $521,238,386.00
- Revenue This Year
- ACIU $85.33
- PANL $8.04
- Revenue Next Year
- ACIU $80.69
- PANL $13.05
- P/E Ratio
- ACIU N/A
- PANL $11.58
- Revenue Growth
- ACIU 4097200.00
- PANL 5.23
- 52 Week Low
- ACIU $2.25
- PANL $5.43
- 52 Week High
- ACIU $5.14
- PANL $9.53
- Technical
- Relative Strength Index (RSI)
- ACIU 45.68
- PANL 33.81
- Support Level
- ACIU $3.10
- PANL $5.51
- Resistance Level
- ACIU $3.25
- PANL $5.86
- Average True Range (ATR)
- ACIU 0.14
- PANL 0.21
- MACD
- ACIU -0.02
- PANL -0.03
- Stochastic Oscillator
- ACIU 13.16
- PANL 5.62
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.